Journal of Clinical Investigation

Papers
(The H4-Index of Journal of Clinical Investigation is 85. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Clinical and immunological features of severe and moderate coronavirus disease 20193496
SARS-CoV-2: a storm is raging869
Deployment of convalescent plasma for the prevention and treatment of COVID-19581
Complement and tissue factor–enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis551
Kinetics of viral load and antibody response in relation to COVID-19 severity460
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent400
Immune responses to stroke: mechanisms, modulation, and therapeutic potential344
SARS–CoV-2 infection of the placenta338
Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population334
Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS–CoV-2296
Early safety indicators of COVID-19 convalescent plasma in 5000 patients293
Distinct clinical and immunological features of SARS–CoV-2–induced multisystem inflammatory syndrome in children275
Recent endemic coronavirus infection is associated with less-severe COVID-19254
Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells223
mRNA vaccine–induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer216
SARS-CoV-2–specific CD8+ T cell responses in convalescent COVID-19 individuals199
Baricitinib restrains the immune dysregulation in patients with severe COVID-19195
Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma181
Insulin signaling in health and disease175
SARS–CoV-2–specific T cell responses and correlations with COVID-19 patient predisposition172
HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer170
Convalescent plasma anti–SARS-CoV-2 spike protein ectodomain and receptor-binding domain IgG correlate with virus neutralization162
Immune escape and immunotherapy of acute myeloid leukemia157
COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes156
Renal tubule Cpt1a overexpression protects from kidney fibrosis by restoring mitochondrial homeostasis144
Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer142
Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations137
Impact of TREM2R47H variant on tau pathology–induced gliosis and neurodegeneration136
Contributions of alveolar epithelial cell quality control to pulmonary fibrosis135
A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti–PD-1 immunotherapy134
TYRO3 induces anti–PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis132
Herpesvirus latency127
Hypoxia-inducible factors and obstructive sleep apnea127
Peripheral CD4+ T cell subsets and antibody response in COVID-19 convalescent individuals123
Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia119
Boosting NAD level suppresses inflammatory activation of PBMCs in heart failure117
TRPV4 channel opening mediates pressure-induced pancreatitis initiated by Piezo1 activation117
IL-17 and immunologically induced senescence regulate response to injury in osteoarthritis117
Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer112
Endothelial C3a receptor mediates vascular inflammation and blood-brain barrier permeability during aging111
IL-1β suppression of VE-cadherin transcription underlies sepsis-induced inflammatory lung injury111
The COVID-19 pandemic and research shutdown: staying safe and productive111
Immune dysregulation as a driver of idiopathic pulmonary fibrosis109
Single residue in CD28-costimulated CAR-T cells limits long-term persistence and antitumor durability109
p53/microRNA-214/ULK1 axis impairs renal tubular autophagy in diabetic kidney disease109
Circular RNA-ZNF532 regulates diabetes-induced retinal pericyte degeneration and vascular dysfunction108
Epigenetic driver mutations in ARID1A shape cancer immune phenotype and immunotherapy108
Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control108
Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation107
IRF4 instructs effector Treg differentiation and immune suppression in human cancer106
Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis105
Hypoxia-inducible factor signaling in pulmonary hypertension103
TREM2 sustains macrophage-hepatocyte metabolic coordination in nonalcoholic fatty liver disease and sepsis103
Pharmacological treatment of hyperglycemia in type 2 diabetes102
Antigen-driven clonal selection shapes the persistence of HIV-1–infected CD4+ T cells in vivo101
ATM inhibition enhances cancer immunotherapy by promoting mtDNA leakage and cGAS/STING activation101
HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models100
BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of health care workers100
Sleeping Beauty–engineered CAR T cells achieve antileukemic activity without severe toxicities98
Bone marrow adipogenic lineage precursors promote osteoclastogenesis in bone remodeling and pathologic bone loss98
Microenvironmental Th9 and Th17 lymphocytes induce metastatic spreading in lung cancer97
Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation97
Melatonin inhibits cytosolic mitochondrial DNA–induced neuroinflammatory signaling in accelerated aging and neurodegeneration97
Age-determined expression of priming protease TMPRSS2 and localization of SARS-CoV-2 in lung epithelium96
Preventing cytokine storm syndrome in COVID-19 using α-1 adrenergic receptor antagonists96
Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection94
Osteocyte necrosis triggers osteoclast-mediated bone loss through macrophage-inducible C-type lectin93
Circadian rhythm influences induction of trained immunity by BCG vaccination93
Biomarkers of inflammation and repair in kidney disease progression93
Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1–associated membranous nephropathy92
BCG vaccination in humans inhibits systemic inflammation in a sex-dependent manner92
Lung megakaryocytes are immune modulatory cells92
Similarities and differences between the immunopathogenesis of COVID-19–related pediatric multisystem inflammatory syndrome and Kawasaki disease92
Circulating markers of NADH-reductive stress correlate with mitochondrial disease severity91
Minimal PD-1 expression in mouse and human NK cells under diverse conditions90
COVID-19 threatens health systems in sub-Saharan Africa: the eye of the crocodile88
COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike receptor binding domain88
PD-1 blockade inhibits osteoclast formation and murine bone cancer pain88
Inherited human IFN-γ deficiency underlies mycobacterial disease87
Inhibition of mitophagy drives macrophage activation and antibacterial defense during sepsis86
HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virus85
Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome85
Hypoxia-inducible factors and innate immunity in liver cancer85
Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity85
Upregulation of Rubicon promotes autosis during myocardial ischemia/reperfusion injury85
Impaired complex I repair causes recessive Leber’s hereditary optic neuropathy85
0.073649883270264